Considerations and Challenges in Defining Optimal Iron Utilization in Hemodialysis-Reference-Cited by-同舟云学术

Considerations and Challenges in Defining Optimal Iron Utilization in Hemodialysis

Published:2014-12-26 Issue:6 Volume:26 Page:1238-1247
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Charytan David M.,Pai Amy Barton,Chan Christopher T.,Coyne Daniel W.,Hung Adriana M.,Kovesdy Csaba P.,Fishbane Steven

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference94 articles.

1. The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin

2. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

3. Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease

4. Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia

5. US Food and Drug Administration: US FDA drug safety communication: Modified dosing recommendations to improve the safe use of erythropoiesis-stimulating agents (ESAs) in chronic kidney disease, 2011. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm259639.htm. Accessed June 11, 2014

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of iron therapy with incidence of chronic kidney disease;European Journal of Haematology;2023-09-05

2. Association of oral iron replacement therapy with kidney failure and mortality in CKD patients;Clinical Kidney Journal;2023-08-09

3. Cut-off values of haemoglobin and clinical outcomes in incident peritoneal dialysis: the PDTAP study;Nephrology Dialysis Transplantation;2023-07-17

4. Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial);Scientific Reports;2023-01-23

5. Coronary artery bypass grafting vs. percutaneous coronary intervention in coronary artery disease patients with advanced chronic kidney disease: A Chinese single-center study;Frontiers in Surgery;2023-01-20